Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins.

The complex genetics of human complement C4 with unusually frequent variations in the size and number of C4A and C4B, as well as their neighboring genes, in the major histocompatibility complex has been a hurdle for accurate epidemiological studies of diseases associated with C4. A comprehensive series of novel or improved techniques has been developed to determine the total gene number of C4 and the relative dosages of C4A and C4B in a diploid genome. These techniques include (1) definitive genomic restriction-fragment-length polymorphisms (RFLPs) based on the discrete duplication patterns of the RCCX (RP-C4-CYP21-TNX) modules and on the specific nucleotide changes for C4A and C4B isotypes; (2) module-specific PCR to give information on the total number of C4 genes by comparing the relative quantities of RP1- or TNXB-specific fragments with TNXA-RP2 fragments; (3) labeled-primer single-cycle DNA polymerization procedure of amplified C4d genomic DNA for diagnostic RFLP analysis of C4A and C4B; and (4) a highly reproducible long-range-mapping method that employs PmeI-digested genomic DNA for pulsed-field gel electrophoresis, to yield precise information on the number of long and short C4 genes in a haplotype. Applications of these vigorously tested techniques may clarify the roles that human C4A and C4B gene-dosage variations play in infectious and autoimmune diseases.

[1]  R. Snyderman,et al.  Neutralization of Sensitized Virus by the Fourth Component of Complement , 1969, Science.

[2]  C. Y. Yu,et al.  Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. , 2001, International immunopharmacology.

[3]  C. Y. Yu,et al.  Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. , 1994, The Journal of biological chemistry.

[4]  C. Y. Yu,et al.  Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. , 2002, American journal of human genetics.

[5]  F. Christiansen,et al.  Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. , 1986, Journal of clinical pathology.

[6]  W Miller,et al.  The human and mouse MHC class III region: a parade of 21 genes at the centromeric segment. , 2000, Immunology today.

[7]  R. Hruban,et al.  Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. , 1999, Transplantation.

[8]  G. Tsokos,et al.  Molecular aberrations in human systemic lupus erythematosus. , 2000, Molecular medicine today.

[9]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[10]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[11]  B. Dupont,et al.  Two HLA-linked loci controlling the fourth component of human complement. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Volanakis.  The human complement system in health and disease , 1998 .

[13]  R. O'rourke,et al.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. , 1975, The Journal of clinical investigation.

[14]  B. Olaisen,et al.  The C4 system: quantitative studies of different genotypes. , 1980, Immunobiology.

[15]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[16]  Russell Higuchi,et al.  Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions , 1993, Bio/Technology.

[17]  J. Brems,et al.  Plasma C3a and C4a levels in liver transplant recipients: a longitudinal study. , 2000, Immunopharmacology.

[18]  A. Feinberg,et al.  Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios , 2000, Nature Genetics.

[19]  G. Riethmüller,et al.  Capillary deposition of C4d complement fragment and early renal graft loss. , 1993, Kidney international.

[20]  D. Jack,et al.  Mannose‐binding lectin: targeting the microbial world for complement attack and opsonophagocytosis , 2001, Immunological reviews.

[21]  Porter Rr.  Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. , 1983 .

[22]  P. Butko,et al.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Alper,et al.  Inherited structural polymorphism of the fourth component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Köhl,et al.  Anaphylatoxins and infectious and non-infectious inflammatory diseases. , 2001, Molecular immunology.

[25]  H. Colten,et al.  Regulation of Complement Protein Gene Expression , 1998 .

[26]  F. Christiansen,et al.  Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis , 1990, The Journal of experimental medicine.

[27]  T. Welch,et al.  C4B deficiency: a risk factor for bacteremia with encapsulated organisms. , 1990, The Journal of infectious diseases.

[28]  I. Dunham,et al.  Direct observation of the gene organization of the complement C4 and 21- hydroxylase loci by pulsed field gel electrophoresis , 1989, The Journal of experimental medicine.

[29]  M. Petzl-Erler,et al.  Major histocompatibility complex (MHC) class III genetics in two Amerindian tribes from Southern Brazil: the Kaingang and the Guarani , 1997, Human Genetics.

[30]  K. Belt,et al.  Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region. , 1985, The EMBO journal.

[31]  P. White,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2000, Endocrine reviews.

[32]  O. Ruuskanen,et al.  Homozygous deletion of the CYP21A-TNXA-RP2-C4B gene region conferring C4B deficiency associated with recurrent respiratory infections. , 1999, Human immunology.

[33]  S. Gitelman,et al.  Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus , 1992, Molecular and cellular biology.

[34]  C. Y. Yu,et al.  The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates , 2004, Immunogenetics.

[35]  E. Sim,et al.  Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.

[36]  C. West,et al.  The effect of null C4 alleles on complement function. , 1985, Clinical immunology and immunopathology.

[37]  T. Strachan,et al.  Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21‐hydroxylase and complement C4 gene repeats in 21‐hydroxylase deficiency haplotypes. , 1989, The EMBO journal.

[38]  Bi Zhou,et al.  Deficiencies of Human Complement Component C4a and C4b and Heterozygosity in Length Variants of RP-C4-CYP21-TNX (Rccx) Modules in Caucasians , 2000, The Journal of experimental medicine.

[39]  A. Willis,et al.  The reaction mechanism of the internal thioester in the human complement component C4 , 1996, Nature.

[40]  P. Schneider,et al.  Reference Typing Report for Complement Component C4 , 1999, Experimental and Clinical Immunogenetics.

[41]  P. Hughes,et al.  C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus , 1990, Clinical and experimental immunology.

[42]  C. Alper,et al.  Genetic polymorphism of human complement C4 and detection of heterozygotes , 1979, Nature.

[43]  P. Schneider,et al.  The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition , 2001, Immunogenetics.